Commissioned by NHS England for treatment and prevention of  bleeding in adults with von Willebrand disease. NHS England commissioning policy

 Gastroenterology specialist initiation only.

Only for patients with IBD unable to tolerate other iron preparations

Each capsule contains 30mg elemental iron

Each tablet contains ferrous sulfate 200mg equivalent to 65mg elemantal iron

Contains 27.5mg elemental iron per 5ml

Each tablet contains ferrous fumarate 322mg (equivalent to 100mg elemental iron) and folic acid 0.35mg

Licensed for use in second and third trimester of pregnancy for prophylaxis against iron deficiency and megaloblastic anaemia of pregnancy

Drug of choice in antenatal and postnatal women. See local Trust Guideline.

For use only when patients are unable to receive hydroxocobalamin injections (e.g. during COVID-19).

Self Care Medicine: Patients should be recommended to self purchase unless they meet the exception criteria outlined in the NHS England Guidance on conditions for which over the counter items should not routinely be prescribed in primary care (section 4.1.2 Vitamins and Minerals)

For use only when patients are unable to receive hydroxocobalamin injections (e.g. during COVID-19).

Self Care Medicine: Not usually suitable for prescribing on the NHS. Patients should be recommended to self purchase unless they meet the exception criteria outlined in the NHS England Guidance on conditions for which over the counter items should not routinely be prescribed in primary care (section 4.1.2 Vitamins and Minerals)

 for atypical haemolytic uraemic syndrome (see NICE HST1 guidance)

 Non-formulary for relapsing NMO (see NICE TA647 terminated appraisal link below).

also for paediatric renal patients

For use as per commissioning criteria set by NHS England

For use as per commissioning criteria set by NHS England

 Consultant haematologist recommendation only

 Expected date of UK availability November 2020

Specify brand

 For sarcoma only

For use as per commissioning criteria set by NHS England

 Powder for oral or rectal suspension

 for acute use

 for chronic use

For use only in accordance with recommendations in NICE TA623

For use only in accordance with recommendations in NICE TA599

 Nutrition team only. Patients may prepare themselves following advice and recipe from specialist/nutrition team.

 Unlicensed

 - Electrolade on FP10

 Restricted - for specialist cardiac surgery use only. For administration into renal arteries as renal protection during open thoracoabdominal aortic aneurysm repair surgery.

 use for this indication is off label

Classed as a Medical device - CE Marked

 For use in Southampton Children’s Hospital as alternative to compound sodium lactate (Hartmann’s) and as standard fluid of choice.

 Contains potassium (K+) 5mmol/L

Sodium chloride 0.18% and glucose 4% intravenous infusion

Sodium chloride 0.45% and glucose 2.5% intravenous infusion

Sodium chloride 0.45% and glucose 5% intravenous infusion

Sodium chloride 0.9% and glucose 5% intravenous infusion

Sodium chloride 0.45% intravenous infusion

Sodium chloride 0.9% intravenous infusion

Sodium chloride 5% intravenous infusion

Glucose 5% intravenous infusion

Glucose 10% intravenous infusion

Glucose 20% intravenous infusion

Glucose 50% intravenous infusion

Potassium chloride 0.2% and glucose 5% (containing approx. 13.5mmol potassium chloride) 500ml bags

Potassium chloride 0.2% and glucose 5% (containing approx. 27mmol potassium chloride) 1L bags

Potassium chloride 0.3% and glucose 5% (containing 40mmol potassium chloride) 1L bags

Potassium chloride 0.15%, sodium chloride 0.45% and glucose 5% (containing 10mmol potassium chloride) 500ml bags

Potassium chloride 0.15%, sodium chloride 0.45% and glucose 10% (containing 10mmol potassium chloride) 500ml bags

Potassium chloride 0.15%, sodium chloride 0.18% and glucose 10% (containing 10mmol potassium chloride) 500ml bags

Potassium chloride 0.2% and glucose 5% (containing approx. 13.5mmol potassium chloride) 500ml bags

Potassium chloride 0.2% and glucose 5% (containing approx. 27mmol potassium chloride) 1L bags

Potassium chloride 0.2% and sodium chloride 0.9% (containing approx. 13.5mmol potassium chloride) 500ml bags

Potassium chloride 0.2% and sodium chloride 0.9% (containing approx. 27mmol potassium chloride) 1L bags

Potassium chloride 0.2%, glucose 4% and sodium chloride 0.18% (containing approx. 13.5mmol potassium chloride) 500ml bags

Potassium chloride 0.2%, glucose 4% and sodium chloride 0.18% (containing approx. 27mmol potassium chloride) 1L bags

Potassium chloride 0.3% and sodium chloride 0.9% (containing 20mmol potassium chloride) 500ml bags

Potassium chloride 0.3% and sodium chloride 0.9% (containing 40mmol potassium chloride) 1L bags

Potassium chloride 0.3%, sodium chloride 0.45% and glucose 5% (containing 20mmol potassium chloride) 500ml bags

Sodium bicarbonate 1.26%, 1.4%, 2.74%, 4.2% intravenous infusion

Sodium bicarbonate 8.4% intravenous infusion

Human albumin 4.5% solution

Human albumin 20% solution

 In line with clinical commissioning policy  

Chewable tablets first-line.

Effervescent tablets reserved to aid administration in those unable to take chewable tablets. 

Choose brand with lowest acquisition cost and prescribe by brand name to avoid confusion.

Refer to section 9.6.4 for calcium and vitamin D3.

  Formerly Sandocal^®

Chewable tablets first line.

0.51mmol/ml of Calcium

Specialist recommendation for paediatric patients only.

Licensed as a nutritional supplement, not a medicine.

Primary care to prescribe by brand name.

 Endocrinologist use only

 unlicensed

 Unlicensed

If compliance problems with magnesium glycerophosphate

50% (5g in 10ml; 1g in 2ml)

20% (10g in 50ml)  unlicensed - For use within maternity at Princess Anne hospital

10% (1g in 10ml)

 unlicensed

First line intravenous choice

For hyperphosphataemia of chronic renal failure in patients undergoing dialysis

 unlicensed

Only when calcium-containing products not tolerated

Only when calcium-containing products not tolerated

 unlicensed

Approved for use at UHS on Intensive Care only

 Not a licensed medicine - nutritional supplement.

 Not prescribable on FP10 

 Restricted use - see RMOC Position Statement for recommendations on prescribing oral vitamin B supplements.

[Note: UHS may prescribe vitamin B compound strong tablets for patients with Wernicke-Korsakoff syndrome - in this case all supplies (total 1 month) will be made by the hospital].

 In rare cases when vitamin B complex prescribing is justified, Vitamin B compound strong should be used in preference to vitamin B compound tablets.

Effervescent tablet for mouthcare only

Chewable tablets first-line. Effervescent and film-coated tablets reserved to aid administration in those unable to take chewable tablets. 

Note that different formulations have different amounts of colecalciferol and calcium.

Choose brand with lowest acquisition cost and prescribe by brand name to avoid confusion. 

Preferred brands in primary care: Accrete D3 or TheiCal D3

 Products that are UK licensed medicines should be prescribed and supplied wherever possible

Local West Hants CCG guidance can be found here

Injection is  unlicensed

Tablets are  unlicensed

Konakion MM paediatric injection can be given orally

TTO use only

The contents of one capsule should be administered by cutting the narrow tubular tip off and squeezing the liquid contents into the mouth.

Vitamin and mineral supplements for use when recommended by a specialist in patients with cystic fibrosis.

Specialists to ensure preferred formulation and dose is clearly communicated to primary care prescribers.

Alternative to Dalivit drops on Neonatal Unit

Fat-soluble vitamin supplements for use when recommended by specialist in patients with cystic fibrosis.

Specialists to ensure preferred formulation and dose is clearly communicated to primary care prescribers.

For adults with poor swallowing, who are nil by mouth or who require medicine administration through an enteral feeding tube

 unlicensed

 Specialist use only in accordance with NICE HST8 guidance 

 Specialist use only. For treatment of Wilson's disease only in accordance with NHS England Clinical Commissioning Policy.

 Not routinely stocked at UHS. If required please liaise with divisional lead pharmacist. 

[N.B. Available as trientine dihydrochloride 300mg capsules and trientine tetrahydrochloride (Cuprior) 150mg tablets. NHS England confirm that both formulations will be commissioned]

 In line with NHSE specialist commissioning criteria

 Unlicensed

 unlicensed

 unlicensed